Department of Error (DOI:10.1016/S0140-6736(07)61344-0);Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial

Lancet

Volumn 370, Issue 9588, 2007, Pages 676-684

  Annane, Djillali ^a   Vignon, Philippe ^b   Renault, Alain ^c   Bollaert, Pierre Edouard ^d   Charpentier, Claire ^d   Martin, Claude ^e   Troché, Gilles ^f   Ricard, Jean Damien ^g   Nitenberg, Gérard ^h   Papazian, Laurent ⁱ   Azoulay, Elie ^j   Bellissant, Eric ^k  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e HÔPITAL NORD   (France)

^f CH   (France)

^g HÔPITAL LOUIS MOURIER   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ HÔPITAL SAINTE MARGUERITE   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; NORADRENALIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FRANCE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK;

EID: 34548132089     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61476-7     Document Type: Erratum

References (27)

1. Martin G., Mannino D., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
2. Annane D., Aegerter P., Jars-Guincestre M., Guidet B., and for the CUB-Réa Network. Current epidemiology of septic shock: the CUBRea Network. Am J Respir Crit Care Med 168 (2003) 165-172
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864-874
4. Raphael J., Antony I., Bellissant E., et al. Utilisation des cathécolamines au cours du choc septique (adultes-enfants). Réan Urg 5 (1996) 441-450
5. Dellinger R., Carlet J., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
6. Hollenberg S., Ahrens T., Annane D., et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32 (2004) 1928-1948
7. Levy B., Bollaert P., Charpentier C., et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 23 (1997) 282-287
8. Meier-Hellmann A., Reinhart K., Bredle D., Specht M., Spies C., and Hannemann L. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 25 (1997) 399-404
9. Duranteau J., Sitbon P., Teboul J., et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 27 (1999) 893-900
10. De Backer D., Creteur J., Silva E., and Vincent J. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?. Crit Care Med 31 (2003) 1659-1667
11. Day N., Phu N., Bethell D., et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic hemodynamics in severe infection. Lancet 348 (1996) 219-223
12. Seguin P., Bellissant E., Le Tulzo Y., et al. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 71 (2002) 381-388
13. Seguin P., Laviolle B., Guinet P., Morel I., Mallédant Y., and Bellissant E. Dopexamine and norepinephrine vs epinephrine on gastric perfusion in septic shock patients: a randomized study. Crit Care 10 (2006) R32
14. Mullner M., Urbanek B., Havel C., Losert H., Waechter F., and Gamper G. Vasopressors for shock. Cochrane Database Syst Rev 3 (2004) CD003709.
15. McCabe W., and Jackson G. Gram negative bacteremia. I. Etiology and ecology. Arch Intern Med 110 (1962) 847-855
16. Le Gall J., Lemeshow S., and Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270 (1993) 2957-2963
17. Vincent J., Moreno R., Takala J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22 (1996) 707-710
18. Chaix C., Durand-Zaleski I., Alberti C., and Brun-Buisson C. A model to compute the medical cost of intensive care patients. Pharmacoeconomics 15 (1999) 573-582
19. Annane D., Bellissant E., and Cavaillon J. Septic shock. Lancet 365 (2005) 63-78
20. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
21. O'Brien P., and Fleming T. A multiple testing procedure for clinical trials. Biometrics 35 (1979) 549-556
22. Pocock S., Assmann S., Enos L., and Kasten L. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 21 (2002) 2917-2930
23. Annane D., Sebille V., Troche G., Raphael J., Gajdos P., and Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283 (2000) 1038-1045
24. Martin G., Mannino D., and Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 34 (2006) 15-21
25. Bernard G., Vincent J., Laterre P., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
26. Sakr Y., Reinhardt K., Vincent J., et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 34 (2006) 589-597
27. Levy B., Gibot S., Franck P., Cravoisy A., and Bollaert P. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 365 (2005) 871-875